Pharmaceutical stakeholders have been given until 15 February to comment on a bill in New Zealand that seeks to modernize the way in which medicines and medical devices are regulated and will replace the country’s decades-old legislation for health care products.
The Therapeutic Products Bill, which underwent its first reading in parliament on 14 December 2022, was released for public consultation having reached the Select Committee stage.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?